David Silberman
Net worth: 93 365 $ as of 2026-05-30
Net worth: 93 365 $ as of 2026-05-30
David Silberman currently works at Nasus Pharma Ltd., as Director from 2025 and Compugen Ltd., as Chief Financial Officer from 2024.
Mr. Silberman also formerly worked at Teva Pharmaceutical Industries Ltd., as Senior Manager-Global Internal Audit from 2018 to 2021 and Oramed Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Treasurer from 2021 to 2022.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
COMPUGEN LTD. 0.04% | 2026-03-17 | 35,500 ( 0.04% ) | 93 365 $ | 2026-05-30 |
NASUS PHARMA LTD. -.--% | 2026-03-24 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| COMPUGEN LTD. | Director of Finance/CFO | 2024-08-14 |
| NASUS PHARMA LTD. | Director/Board Member | 2025-08-10 |
| Companies | Position | End |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Director of Finance/CFO | 2022-01-08 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Comptroller/Controller/Auditor | 2021-04-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Compugen Ltd.
Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
Oramed Pharmaceuticals, Inc.
Oramed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Nasus Pharma Ltd.
Nasus Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops powder-based intranasal products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions